These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22148589)

  • 21. Comparison of homology models and X-ray structures of the nuclear receptor CAR: assessing the structural basis of constitutive activity.
    Windshügel B; Jyrkkärinne J; Vanamo J; Poso A; Honkakoski P; Sippl W
    J Mol Graph Model; 2007 Jan; 25(5):644-57. PubMed ID: 16831563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small molecule somatostatin receptor subtype 4 (sst
    Szőke É; Bálint M; Hetényi C; Markovics A; Elekes K; Pozsgai G; Szűts T; Kéri G; Őrfi L; Sándor Z; Szolcsányi J; Pintér E; Helyes Z
    Neuropharmacology; 2020 Nov; 178():108198. PubMed ID: 32739276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).
    Floquet N; M'Kadmi C; Perahia D; Gagne D; Bergé G; Marie J; Banères JL; Galleyrand JC; Fehrentz JA; Martinez J
    J Mol Biol; 2010 Jan; 395(4):769-84. PubMed ID: 19782690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28.
    Panetta R; Greenwood MT; Warszynska A; Demchyshyn LL; Day R; Niznik HB; Srikant CB; Patel YC
    Mol Pharmacol; 1994 Mar; 45(3):417-27. PubMed ID: 7908405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
    Goetz A; Lanig H; Gmeiner P; Clark T
    J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
    Zhorov BS; Ananthanarayanan VS
    Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
    Grace CR; Durrer L; Koerber SC; Erchegyi J; Reubi JC; Rivier JE; Riek R
    J Med Chem; 2005 Jan; 48(2):523-33. PubMed ID: 15658866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.
    Wurtz JM; Egner U; Heinrich N; Moras D; Mueller-Fahrnow A
    J Med Chem; 1998 May; 41(11):1803-14. PubMed ID: 9599231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
    Roy KK; Saxena AK
    J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14.
    Ozenberger BA; Hadcock JR
    Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
    Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
    Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative modeling of human kappa opioid receptor and docking analysis with the peptide YFa.
    Patra MC; Kumar K; Pasha S; Chopra M
    J Mol Graph Model; 2012 Mar; 33():44-51. PubMed ID: 22172315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
    Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
    J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and validation of a RET TK catalytic domain by homology modeling.
    Tuccinardi T; Manetti F; Schenone S; Martinelli A; Botta M
    J Chem Inf Model; 2007; 47(2):644-55. PubMed ID: 17295463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
    Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
    Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly potent cyclic disulfide antagonists of somatostatin.
    Hocart SJ; Jain R; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 1999 Jun; 42(11):1863-71. PubMed ID: 10354394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.
    Zhang Y; Sham YY; Rajamani R; Gao J; Portoghese PS
    Chembiochem; 2005 May; 6(5):853-9. PubMed ID: 15776407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of the structure of human phosphodiesterase-2 in a bound state and its binding with inhibitors by molecular modeling, docking, and dynamics simulation.
    Hamza A; Zhan CG
    J Phys Chem B; 2009 Mar; 113(9):2896-908. PubMed ID: 19708117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.